NIH-funded research R21 grant

How EV‑D68 can cause spinal cord damage that leads to paralysis

Official title: Delineating the kinetics of spinal pathology in the EV-D68 infected ferret model

Funded at Henry M. Jackson Fdn for the Adv Mil/med · NIH-11270647 · Data updated 2026-11-12

This project follows how EV‑D68 infection leads to spinal cord damage that can cause polio‑like paralysis in children, using ferrets to track damage over time.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionHenry M. Jackson Fdn for the Adv Mil/med
NIH-funded
Lab location1 site (Bethesda, United States)
Project startFebruary 1, 2025
Project endJanuary 31, 2027
Funding year2026
Award (this year)$186,441
NIH project number5R21AI190739-02
Project IDNIH-11270647 on NIH RePORTER

Who could benefit from this research

Could help

Children who have had or are at risk for EV‑D68–related acute flaccid myelitis would be the eventual beneficiaries, though this grant uses animal models rather than enrolling patients.

Less likely to help

People without EV‑D68 exposure, adults with paralysis from other causes, or patients with long‑standing irreversible spinal damage are unlikely to directly benefit from this animal‑model study.

What this research studies

EV‑D68 is a reemerging virus that can cause acute flaccid myelitis (AFM), a polio‑like paralysis in children. Researchers will develop and use an immunocompetent ferret model to mimic the spinal cord disease seen in children. They will track spinal damage over time and study the role of spinal glial (support) cells in driving that damage. The goal is to better explain why some infections lead to paralysis and to point toward targets for future treatments or prevention.

Why it matters

Potential benefit: If successful, this work could reveal how EV‑D68 damages the spinal cord and help guide development of treatments or vaccines to prevent AFM in children.

How similar studies have gone: Previous neonatal and immunodeficient mouse studies have provided useful clues but do not fully replicate AFM in children, so the ferret model is a relatively new and unproven approach.

Where this research is happening

  • Henry M. Jackson Fdn for the Adv Mil/med
    Bethesda, United States
    Active

Researchers

  • Principal investigator: Mattapallil, Joseph John — Henry M. Jackson Fdn for the Adv Mil/med
  • Study coordinator: Mattapallil, Joseph John

Related research

Other NIH-funded projects on the same topics.

  • Cooperation partners of SETBP1 in AML development

    This grant explores how SETBP1 and AF9 (MLLT3) work together to drive acute myeloid leukemia and whether targeting related epigenetic regulators could help treat aggressive CK-AML.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11625528

  • U.S. Military HIV Research Program Clinical Trials Unit expansion

    A nationwide network of clinical trial sites is being expanded to test HIV prevention and treatment approaches through DAIDS-supported trials.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11609389

  • Novel protein biomarkers of chronic pain in adults using a pain registry biobank

    A study in adults with chronic pain will look for new protein biomarkers in blood samples to understand better why pain persists and how to improve treatment.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11498721

  • Tailored antibody cures for HIV using AI and vaccines

    A study to design personalized antibody-based strategies to achieve HIV remission, using lab experiments and computer models to tailor vaccines or antibody treatments to individuals or small groups.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11483233

  • Understanding how antibody protection works using 3D protein structures

    Researchers will build a 3D-based method to see which viral features relate to prevention by antibodies, using data from people in HIV vaccine and monoclonal antibody trials.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11470978

  • Military HIV Clinical Network

    This program runs HIV and TB prevention and treatment clinical studies for adults in military-associated and high-HIV-burden communities.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11459071

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.